The Access to care: Czech Republic event.
Migraine is one of the most common neurological diseases. Nevertheless, it is underestimated and still underdiagnosed and undertreated throughout Europe. Patients who struggle with this disease are subsequently limited in their personal and professional lives, which has, among other things, a secondary social and economic impact on them.
We decided to contribute to changing this situation. Patient organization Migréna-help in cooperation with the European Migraine & Headache Alliance (EMHA), the Czech Headache Society and the pharmaceutical industry organized a professional seminar “Improving Access to Migraine Care in Czechia”, which took place on September 13, 2022, in the event centre Sněmovní 7 in Prague 1.
During the seminar, the participants were introduced to both the issue of migraine and the experiences of Czech patients; together they also discussed the possibilities of ensuring early access to diagnosis and effective treatment for migraine patients. As part of the event, the results of an extensive study prepared by KPMG, which mapped in detail the availability of migraine treatment across the European Union, were also presented, as well as subsequent national studies focused specifically on the experiences of Czech patients.
The seminar was attended by representatives of the state administration, health insurance companies, patient organizations, and the professional public. The seminar was held under the auspices of MUDr. Roman Kraus, MBA, Chairman of the Senate Health Committee of Parliament of the Czech Republic.
